Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Substrate Based Modification in Ventricular Tachycardia: Ablation of the Local Abnormal Ventricular Activity Only

NCT05331716 is registered in ClinicalTrials.gov with University of Kiel as lead sponsor.

NCT NCT05331716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05331716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Substrate Based Modification in Ventricular Tachycardia: Ablation of the Local Abnormal Ventricular Activity Only
Lead sponsor
University of Kiel
Phase
Observational
Overall status
Completed
Start date
January 1, 2019
Completion date
December 31, 2021
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ventricular tachycardia